Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Biodistribution and Anti-tumor Activities of the 131I-labeled Rituximab in Nude Mice Bearing Human Burkitt’s lymphoma

Qiang Zuo, Aimin Li, Xiao Yan and Rongcheng Luo
Clinical Oncology and Cancer Research August 2009, 6 (4) 256-262; DOI: https://doi.org/10.1007/s11805-009-0256-y
Qiang Zuo
Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimin Li
Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Yan
Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rongcheng Luo
Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 6 no. 4 256-262
DOI 
https://doi.org/10.1007/s11805-009-0256-y

Published By 
Cancer Biology & Medicine
History 
  • Received June 8, 2009
  • Accepted July 28, 2009
  • Published online August 1, 2009.

Copyright & Usage 
Copyright © 2009 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Qiang Zuo
  1. Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  1. Aimin Li
  1. Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  1. Xiao Yan
  1. Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  1. Rongcheng Luo⇑
  1. Cancer Center, Nanfang Hospital, the Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  1. Correspondence to: Rongcheng Luo Tel: 86-20-6164 1651 E-mail: nfyywbb{at}126.com
View Full Text
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 6 (4)
Clinical Oncology and Cancer Research
Vol. 6, Issue 4
1 Aug 2009
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution and Anti-tumor Activities of the 131I-labeled Rituximab in Nude Mice Bearing Human Burkitt’s lymphoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Biodistribution and Anti-tumor Activities of the 131I-labeled Rituximab in Nude Mice Bearing Human Burkitt’s lymphoma
Qiang Zuo, Aimin Li, Xiao Yan, Rongcheng Luo
Clinical Oncology and Cancer Research Aug 2009, 6 (4) 256-262; DOI: 10.1007/s11805-009-0256-y

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution and Anti-tumor Activities of the 131I-labeled Rituximab in Nude Mice Bearing Human Burkitt’s lymphoma
Qiang Zuo, Aimin Li, Xiao Yan, Rongcheng Luo
Clinical Oncology and Cancer Research Aug 2009, 6 (4) 256-262; DOI: 10.1007/s11805-009-0256-y
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
  • Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma
  • Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study
Show more Original Article

Similar Articles

Keywords

  • Iodine-131
  • anti-CD20 monoclonal antibody
  • non-Hodgkin’s lymphoma (NHL)
  • intratumoral injection
  • radioimmunotherapy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire